{"id":2,"date":"2022-09-12T14:27:24","date_gmt":"2022-09-12T13:27:24","guid":{"rendered":"https:\/\/sites.dundee.ac.uk\/great-2\/?page_id=2"},"modified":"2023-04-05T14:21:04","modified_gmt":"2023-04-05T13:21:04","slug":"home","status":"publish","type":"page","link":"https:\/\/sites.dundee.ac.uk\/great-2\/","title":{"rendered":"Home"},"content":{"rendered":"\n<p>GREAT-2 is a clinical trial to test a new treatment for bronchiectasis.<\/p>\n\n\n\n<p>People with bronchiectasis frequently get chest infections which are difficult to treat. Approximately one third of people with bronchiectasis become infected with a bacteria called <em>Pseudomonas aeruginosa (P. aeruginosa).<\/em><\/p>\n\n\n\n<p>The purpose of this trial is to test whether an intravenous infusion drip containing a new drug called Gremubamab can reduce the amount of infection with <em>P. aeruginosa.<\/em><\/p>\n\n\n\n<p>The trial is being Sponsored by the University of Dundee &amp; NHS Tayside and is being managed by&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.dundee.ac.uk\/tctu\/\" target=\"_blank\">Tayside Clinical Trials Unit.<\/a><\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"134\" src=\"https:\/\/sites.dundee.ac.uk\/great-2\/wp-content\/uploads\/sites\/201\/2023\/02\/VitalBE-Footer-1024x134.png\" alt=\"\" class=\"wp-image-204\" srcset=\"https:\/\/sites.dundee.ac.uk\/great-2\/wp-content\/uploads\/sites\/201\/2023\/02\/VitalBE-Footer-1024x134.png 1024w, https:\/\/sites.dundee.ac.uk\/great-2\/wp-content\/uploads\/sites\/201\/2023\/02\/VitalBE-Footer-300x39.png 300w, https:\/\/sites.dundee.ac.uk\/great-2\/wp-content\/uploads\/sites\/201\/2023\/02\/VitalBE-Footer-768x101.png 768w, https:\/\/sites.dundee.ac.uk\/great-2\/wp-content\/uploads\/sites\/201\/2023\/02\/VitalBE-Footer-1536x201.png 1536w, https:\/\/sites.dundee.ac.uk\/great-2\/wp-content\/uploads\/sites\/201\/2023\/02\/VitalBE-Footer.png 1731w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>GREAT-2 is a clinical trial to test a new treatment for bronchiectasis. People with bronchiectasis frequently get chest infections which are difficult to treat. Approximately one third of people with bronchiectasis become infected with a bacteria called Pseudomonas aeruginosa (P. aeruginosa). The purpose of this trial is to test whether an intravenous infusion drip containing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/sites.dundee.ac.uk\/great-2\/\" class=\"more-link\">Read more<span class=\"screen-reader-text\"> &#8220;Home&#8221;<\/span><\/a><\/p>\n","protected":false},"author":695,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inspiro_hide_title":false,"footnotes":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/users\/695"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":12,"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":242,"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/pages\/2\/revisions\/242"}],"wp:attachment":[{"href":"https:\/\/sites.dundee.ac.uk\/great-2\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}